Results 51 to 60 of about 20,097 (156)

Outcome of adalimumab monotherapy in paediatric non-infectious uveitis

Pediatric Rheumatology Online Journal, 2023
Background Adalimumab in combination with other disease-modifying antirheumatic drugs (DMARD) such as methotrexate has a proven efficacy in the management of paediatric non-infectious uveitis.
DA Al-Julandani, NK Bagri, N Tsang, S Clarke, A Upadhyay, C Guly, AV Ramanan   +6 more
doaj   +1 more source

Secukinumab in refractory non-infectious anterior uveitis

Frontiers in Ophthalmology
BackgroundSecukinumab is a monoclonal antibody that selectively neutralizes interleukin-17A and has shown efficacy in the treatment of psoriatic arthritis, psoriasis, and axial spondyloarthritis.
Otto M. Olivas-Vergara, Inés Hernanz, Pablo E. Borges-Deniz, Fredeswinda Romero-Bueno, Olga Sanchez-Pernaute, Ester Carreño   +5 more
doaj   +1 more source

Computed tomography long‐term follow‐up of a facial fracture involving the orbit and paranasal sinus

Equine Veterinary Journal, EarlyView.
Abstract Background Fractures of the facial bones involving the orbit are challenging conditions that require surgical treatment. Objectives To describe preoperative and postoperative clinical and computed tomographic findings of an orbital rim fracture repaired using a reconstruction plate. Study Design Case report.
A. Kalinovskiy, C. Lischer, J. C. Eule, K. Thieme, K. Mählmann   +4 more
wiley   +1 more source

Results of intravitreal dexamethasone implant 0.7 mg (Ozurdex®) in non-infectious posterior uveitis [PDF]

International Journal of Ophthalmology, 2015
AIM:To evaluate the safety and efficacy of dexamethasone implant in patients with non-infectious posterior uveitis withcystoid macular edema (CME).METHODS:Retrospective analysis of patients reports with CME secondary to non-infectious uveitis treated ...
Yew Chong Yap, Thomas Papathomas, Ahmed Kamal   +2 more
doaj   +1 more source

Challenges for interpreting results of antimicrobial susceptibility testing for treating infections of foals with Rhodococcus equi

Equine Veterinary Journal, EarlyView.
Abstract Rhodococcus equi is a facultative intracellular pathogen and a major cause of pneumonia in foals worldwide. The standard treatment for affected foals is a combination of a macrolide with rifampicin. The widespread use of this combination has led to the emergence of multidrug‐resistant (MDR) strains of R. equi.
Marlane Geribone Seeger, Letícia Trevisan Gressler, Laura Huber, Sonsiray Alvarez‐Narvaez, Juliana Felipetto Cargnelutti, Angela Ilha Bordin, Sara D. Lawhon, Noah D. Cohen   +7 more
wiley   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

Head &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa   +11 more
wiley   +1 more source

The application of dexamethasone implants in uveitis treatment

Frontiers in Medicine
Uveitis refers to a group of ocular inflammatory diseases that can significantly impair vision. Although systemic corticosteroid therapy has shown substantial efficacy in treating uveitis, extensive use of corticosteroids is associated with significant ...
Tian Zhang, Zhutao Liu, Na Li
doaj   +1 more source

Bilateral Ophthalmoplegia After Neoadjuvant Pembrolizumab for Oral Cavity Squamous Cell Carcinoma

The Laryngoscope, EarlyView.
The role of immune checkpoint inhibition (ICI) therapy in the treatment of head and neck squamous cell carcinoma (HNSCC) is expanding with increased utilization of neoadjuvant and adjuvant pembrolizumab in the setting of locally advanced disease. This report describes the presentation and management of the first known case of pembrolizumab‐induced ...
Leonard E. Estephan, Peter Jacoby, David M. Cognetti, Steven A. Manobianco   +3 more
wiley   +1 more source

Frequency of Brucella canis seropositivity in at‐risk dogs referred for veterinary care in the UK

Veterinary Record, EarlyView.
Abstract Background Brucella canis is a canine pathogen of zoonotic concern. It is not considered endemic in the UK, with most infections diagnosed in travelled dogs or their offspring. Methods Between March 2021 and December 2022, all dogs with a history of travel outside of the UK or clinical signs compatible with brucellosis referred for veterinary ...
Josh Kennils, Simon Cue, Michelle L. Taylor, Emi N. Barker   +3 more
wiley   +1 more source

CD4 Count and Viral Load Differences in HIV Patients with and without Infectious Posterior Uveitis at a Tertiary Hospital in Indonesia

Current Internal Medicine Research and Practice Surabaya Journal
Introduction: The human immunodeficiency virus (HIV) compromises the immune system, making the monitoring of cluster of differentiation (CD4) counts and viral loads critical for assessing disease progression and opportunistic infection risks. Eye-related
Shofa Annesa Hidayat, Ismi Zuhria, Muhammad Vitanata Arfijanto, Reni Prastyani   +3 more
doaj   +1 more source